LIPOTOPE
Live / Applied — Second extension granted (statement of use) (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 13 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98313169
- Mark type
- Stylized text
- Filed
- 13 Dec 2023
- Published for opposition
- 03 Dec 2024
- Attorney of record
- Tamara Carmichael
Goods and services
- Class 005 — Pharmaceuticals: Nasal sprays for medical purposes; Inhalers for medical purposes, namely, weight management; Inhalers for medical purposes, namely, sleep aid; Topical gel for medical and therapeutic purposes, namely, for pain relief; Topical gel for medical and therapeutic purposes, namely, for athletic performance and recovery; Topical gel for medical and therapeutic purposes, namely, the enhancement of sexual arousal and pleasure
Owner
- Lipotope, Inc., Fairfield, CA, US
- Lipotope, Inc., Fairfield, CA, US
Prosecution history
- 15 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2026 — SOU EXTENSION 2 GRANTED
- 14 Jan 2026 — SOU EXTENSION 2 FILED
- 14 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2025 — SOU EXTENSION 1 GRANTED
- 23 Jun 2025 — SOU EXTENSION 1 FILED
- 10 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED